Business Wire

Cybin Announces Results of Shareholders’ Meeting

TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE AMERICAN:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to TherapeuticsTM”, is pleased to announce the voting results for each of the mat


Flora Growth Reports H1 2022 Financial Results

H1 2022 revenue increased to ~$15.0 million, up 604% from H1 2021 and 117% from H2 2021, driven by House of Brands Gross Profit increased to ~$7.0 million, up 547% compared to H1 2021 and 363% compared to H2 2021 Company reaffirms its 2022 revenue g


Miravo Healthcare™ Announces Second Quarter 2022 Results

- Blexten Canadian Prescriptions Increased 17% Year-Over-Year - - Suvexx Canadian Prescriptions Increased 85% Year-Over-Year - - Plans to Wind-Down Manufacturing Facility in Varennes, Québec - Miravo to Host Conference Call/Audio Webcast August 15th